Literature DB >> 7379037

Elevation of serum acid phosphatase in cancers with bone metastasis.

M Tavassoli, M Rizo, L T Yam.   

Abstract

In patients with nonprostatic cancer serum acid phosphatase activity is usually elevated when bone metastasis is present but not when bone metastasis is absent. The fraction responsible for serum enzyme elevation is a normal component of serum; it appears in gel electrophoresis as band 5; and is tartrate-resistant. It is suggested that the origin of acid phosphatase elevation is bone osteoclasts rather than cancer tissue, as is the case with prostatic carcinoma. Determination of serum acid phosphatase activity may be useful in the detection of bone metastasis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7379037     DOI: 10.1002/1097-0142(19800501)45:9<2400::aid-cncr2820450927>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Serum tartrate-resistant acid phosphatase and bone mineral content in postmenopausal osteoporosis.

Authors:  C de la Piedra; R Torres; A Rapado; M Diaz Curiel; N Castro
Journal:  Calcif Tissue Int       Date:  1989-07       Impact factor: 4.333

2.  Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.

Authors:  R Torres; C de la Piedra; A Rapado
Journal:  Calcif Tissue Int       Date:  1991-07       Impact factor: 4.333

3.  Prostatic acid phosphatase and prostate specific antigen in liver disease.

Authors:  A Kadayifci; M Benekli; H Simşek; O Sencan
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

4.  Acute onset-low back pain and hip pain secondary to metastatic prostate cancer: a case report.

Authors:  Natalia Lishchyna; Shawn Henderson
Journal:  J Can Chiropr Assoc       Date:  2004-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.